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Objectives: To decipher the mechanisms and their associated genetic determinants responsible for b-lactam
resistance in a Proteus mirabilis clinical isolate.
Methods: The entire genetic structure surrounding theb-lactam resistance geneswas characterized by PCR, gene
walking and DNA sequencing.
Results:Genes encoding the carbapenemase NDM-1 and the ESBLVEB-6were located in a 38.5 kbMDR structure,
which itself was inserted into a new variant of the Proteus genomic island 1 (PGI1). This new PGI1-PmPEL variant
of 64.4 kbwas chromosomally located, as an external circular form in the P. mirabilis isolate, suggesting potential
mobility.
Conclusions: This is the first known description of the blaNDM-1 gene in a genomic island structure, which might
further enhance the spread of the blaNDM-1 carbapenemase gene among enteric pathogens.
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Introduction
While decreased susceptibility to imipenem is intrinsic in Proteeae,
some Proteus mirabilis exhibit an increased level of resistance to
imipenem (with MICs ranging from 16 to 64 mg/L) due to loss of
outer membrane porin, decreased expression of PBP1a or reduced
binding of imipenem by PBP2.1 The emergence of MDR P. mirabilis
isolates producing acquired ESBLs, AmpCand carbapenemases has
also been described.2 The carbapenemases identified previously
in P. mirabilis are the Ambler class A b-lactamase KPC-2,3 the
class B [metallo-b-lactamases (MBLs)] VIM-1 and NDM-1,4 and
the carbapenem-hydrolysing class D b-lactamase OXA-23.5
The blaNDM-1 gene, firstly identified froma Klebsiella pneumoniae
isolate, has been described in most enterobacterial species, but
also in Vibrio cholerae, Pseudomonas spp. and Acinetobacter spp.6
In Enterobacteriaceae, the blaNDM-1 gene is most often located on
plasmids.7 Plasmid acquisition occurs by conjugation or mobiliza-
tion in Enterobacteriaceae; nevertheless, integrative mobilizable
elements have been described in Salmonella spp., e.g. Salmonella
genomic island 1 (SGI1).8 The SGIs may contain MDR regions with
genes encoding b-lactamases (e.g. ESBLs) and resistance to quino-
lones (Qnr), chloramphenicol/florfenicol, tetracycline and amino-
glycosides. Variants of SGI1 have been classified from SGI1-A
to SGI1-V, corresponding to variants of the MDR region.9–13 The
integration of SGI1 into the chromosome of Salmonella spp. occurs
at the last 18 bp of the 3′-end of the thdF gene.8 Since this con-
served integration site has been also identified in diverse bacteria,
it was hypothesized that P. mirabilis could be an acceptor of SGI
independently of Salmonella spp., although SGI1 have been excep-
tionally detected in P. mirabilis isolates.9–14 Recently a new resist-
ance genomic island belonging to the same family as SGI1 and
named PGI1 (Proteus genomic island 1) has been described in
P. mirabilis.
We describe here the co-occurrence of the carbapenemase
gene blaNDM-1 together with the ESBL gene blaVEB-6 in a new
SGI1 variant from a clinical P. mirabilis isolate.
Materials and methods
Bacterial strains and antibiotic susceptibility testing
P. mirabilis PEL was isolated from a urine sample recovered from a patient
hospitalized at Chambery hospital in France in 2012. P. mirabilis PEL was
identified using the API 20E system (bioMe´rieux, La Balme les Grottes,
France). Escherichia coli TOP10 (Life Technologies, Cergy-Pontoise,
France), E. coli K-12 strain BM148 and E. coli J53 reference strain were
used in cloning and conjugation experiments. MICs were determined by
Etest (bioMe´rieux) and were interpreted according to CLSI breakpoints.15
The production of putative carbapenemases and ESBLs was evaluated
using the Carba NP test and the ESBL NDP test, respectively, as previously
described.16,17
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PCR and sequencing
A PCR approach was used to detect different types of b-lactamase genes
as previously described.4 Cloning experiments were performed using XbaI
restriction, a pBKCMV plasmid, expression in E. coli TOP10 and selection on
trypticase soy agar supplemented with ticarcillin (50 mg/L) and kanamy-
cin (30 mg/L). Plasmid DNAs were extracted using Qiagen columns
(Qiagen) and sequenced on an ABI3130 sequencer (Applied Biosystems,
Les Ulis, France).4 PCR mapping of PGI1 was performed with primers cho-
sen in the island backbone according to sequences available in the
GenBank database (AF261825), and primers PGI1circ1 and PGI1circ2
were used for the detection of a circular extrachromosomal form of SGI1.8
SGI mobilization assays
Conjugal transfer was attempted by liquid and solid mating-out assays
using a rifampicin-resistant E. coli J53 strain. Before mobilization experi-
ments, plasmid R55was introduced into P. mirabilis PEL donor by liquid con-
jugation with E. coli K-12 strain BM14 carrying R558 and selection on agar
containing gentamicin (40 mg/L) and ceftazidime (2 mg/L). Mobilization of
the circular form of PGI1 was attempted by liquid and solid mating-out
assays with P. mirabilis PEL (pR55) as a donor and in vitro-selected
rifampicin-resistant Salmonella enterica serovar Typhimurium LT2 as a
recipient strain. Agar plates containing ceftazidime (2 mg/L) and rifampicin
(200 mg/L) were used for selection of S. enterica transconjugants.
Nucleotide sequence accession number
The nucleotide sequence of the PGI1 variant from P. mirabilis PELwas sub-
mitted to GenBank under accession number KF856624.
Results and discussion
Susceptibility testing and carbapenemase identification
P. mirabilis isolate PELwas resistant to amino- and carboxypenicil-
lins, narrow- and broad-spectrum cephalosporins, moxalactam
and aztreonam (Table S1, available as Supplementary data at
JAC Online). It was resistant to imipenem (MIC of 32 mg/L), but
susceptible to meropenem and ertapenem (MICs of 0.75 and
0.25 mg/L, respectively; Table S1). The association of reduced sus-
ceptibility to imipenem with resistance to all b-lactams including
broad-spectrum cephalosporins and cefoxitin was uncommon.
PCR and sequencing identified the carbapenemase and ESBL
genes blaNDM-1 and blaVEB-6. In addition, P. mirabilis PELwas resist-
ant tomost of the non-b-lactam antibiotics, with the exception of
gentamicin, fosfomycin and rifampicin (data not shown).
Genetic structures surrounding the blaNDM-1 gene
Plasmid pPEL-1, recovered after XbaI cloning experiments, pos-
sessed a 28.1 kb insert and haboured the blaNDM-1 gene bracketed
by insertion sequence ISAba125 and the bleMBL gene encoding
resistance to bleomycin, as previously identified in most
blaNDM-1-positive strains (Figure 1).
18 The DNA fragment encom-
passing ISAba14, blaNDM-1 and ISCR1 (orf513) shared 99% nucleo-
tide identity with a plasmid-borne fragment from Acinetobacter
spp. M131 (accession number JX072963.1) (Figure 1). ISAba14
had been first identified to be associated with the class A
b-lactamase gene blaCARB-14 in Acinetobacter baumannii
19 and
also in NDM-1-producing A. baumannii isolates, but had not been
reported from Enterobacteriaceae isolates to date. Although
ISAba125 is systematically identified upstream of the blaNDM-like
genes,7 its role in the mobilization of this gene has not yet been
demonstrated. In A. baumannii, it is likely that composite trans-
poson Tn125 is at the origin of blaNDM gene acquisition,
20 while
the ISCR1-like elements might be responsible for the mobilization
of blaNDM in Enterobacteriaceae, through a rolling-circle transpos-
ition process or due to homologous recombination between two
copies of ISCR1.21 Noticeably, the blaNDM gene is the product of a
gene fusion event, which has implications for its expression and
subsequent mobility.22
Genetic structure surrounding the blaVEB-6 gene
The close genetic environment of the blaVEB-6 gene shared 98%
nucleotide identity with that previously reported on SGI1-V in a
P. mirabilis isolate recovered in France in 2011.9 However, SGI-V
had a different backbone as compared with the novel PGI
(named PGI-PmPEL) identified here (Figure 1).
Genetic structure of the mer operon
Downstream of the blaNDM-1-containing locus, a gene encoding a
transposase of the Tn3 family was identified, showing 88%
nucleotide identity with that of ISPa40. At the right-hand end of
the complex integron, a region corresponding to the Tn501 mer-
cury resistance module was identified, followed by the Tn5053
transposition module, containing four genes involved in transpos-
ition, i.e. tniA, tniB, tniQ and tniR. Sequencing of the 3′-end of plas-
mid pPEL showed that the antibiotic resistance gene cluster was
surrounded by inverted repeats IRt and DR-R of the SGI1 type
(Figure 1).8
Characterization of the PGI1 backbone
The 67 kb PGI1-PmPEL was integrated between the thdF and
hipB/hipA chromosomal genes (Figure 1). The sequences of spe-
cific recombination sites (attP and attB sites) have been identified
(Figure 1).8 The MDR region here interrupted the C1566 orf from
Salmonella Heidelberg strain 7, suggesting that a large deletion
had occurred from the res gene (C1584) to C1566 (Figure 1a).
The DR-R was located 109 bp downstream of orf C1564. This
PGI1-PmPEL shared 99% identity with the two recently described
PGI1-PmCHA and PGI1-PmCHE. Nevertheless, the same synteny
was highly conserved between PGI1 and SGI1 backbones, sug-
gesting that both islands belong to the same genomic island
family.
Detection of an extrachromosomal form of PGI1
Most SGI1 have lost the ability of horizontal transfer. However,
some integrative and conjugative elements (ICEs) can excise
from the chromosome by a site-specific recombination, leading
to the formation of circular extrachromosomal elements, which
may be transferred by conjugation and integrated in a site-specific
fashion into the recipient chromosome.8 PCR experiments with
PGI1circ1/2 primers confirmed the presence of a circular extra-
chromosomal form of PGI1-PmPEL in P. mirabilis PEL in the pres-
ence or absence of helper plasmid pR55.8 Mobilization in trans of
this circular form of PGI1-PmPEL was attempted after
SGI1-located blaNDM-1 gene
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Figure 1. Schematic view of the variant SGI1-Was integrated in P.mirabilis strain PEL. (a) The overall structure of the SGI1 backbone is represented as reported by Doublet et al.8 The 18 bp
direct repeats (DR-R and DR-L) bracketing the module are shown. IRi and IRt are 25 bp imperfect inverted repeats defining the left and right ends of the MDR region encompassing the
blaNDM-1 gene. The different parts of the MDR region of this study (b, 3) have been compared with that of the blaNDM-1-harbouring plasmid pM131 from A. baumannii sp. (GenBank:
JX072963.1) (b, 1) and pNDM-1 Saitama from K. pneumoniae (GenBank: AB759690) (b, 2), in SGI1-V from P. mirabilis14 (b, 4), in SGI1-O from P. mirabilis13 (b, 5) and in SGI1-K5 from
S. enterica24 (b, 6). Common features are highlighted with grey shading. Gene names are as follows: mobA, mobilization protein; orf, open reading frame; IS, insertion sequence; aph,
aminoglycoside phosphotransferase; bla, b-lactamase; bleMBL, bleomycin resistance protein; trf, phosphoribosylanthranilate isomerase; odp, oxidoreductase domain protein; dct, divalent
cation tolerance protein; groES and groEL, chaperonins; mpi, resolvase; ISCR, insertion sequence common region; intI1, integrase; aac, aminoglycoside acetyltransferase; dhfr,
dihydrofolate reductase; aad, aminoglycoside adenylyltransferase; qacED1, ethidium bromide resistance protein; sulI, dihydropteroate synthase; ampR, ampC regulator gene; tnp,
transposase; mer, mercury resistance genes; tni, transposition protein; arr3, rifampicin ADP-ribosylatin transferase; smrt, retron-type reverse transcriptase; armA, ArmA 16S rRNA
methylase; tnp, transposase; mel, macrolide efflux protein; and mph2, macrolide 2′-phosphotransferase.
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complementation with plasmid R55 as described by Doublet
et al.8 and Douard et al.,23 but remained unsuccessful.
Conclusions
This study identified a new variant of PGI1 in a multiresistant
P. mirabilis clinical isolate. This is the first known description of
the blaNDM-1 gene, and more generally of a carbapenemase-
encoding gene, in a resistance island element. Notably, the
blaNDM-1 gene was associated with the ESBL gene blaVEB-6 in this
same ICE, thus leading to a stable structure conferring a high
level of resistance to all b-lactams, including aztreonam. The
results obtained here indicate that resistance gene exchanges
may occur between Acinetobacter spp. and P. mirabilis, as sug-
gested by the occurrence of ISAba14 in P. mirabilis PEL. The likely
scenario might be that Acinetobacter spp. may have been the first
target of blaNDM-1 acquisition and then the structurewas captured
by Salmonella spp. to finally target in P. mirabilis or directly cap-
tured by a resident PGI in P. mirabilis. The latter may be the
most probable, as blaNDM-1 has not been identified on SGI1-like
structures in Salmonella spp. to date. This is an additional clue
confirming the possible role of Acinetobacter spp. as a source of
antibiotic resistance for enterobacterial species. In addition, our
study showed that such a genetic structure harbouring several
clinically relevant resistance genes might be stabilized through
chromosomal integration and then be vertically transmitted with-
out risk of plasmid loss.
Note added in proof
The recent results obtained by Siebor & Neuwirth (J Antimicrob Chemother
2014; 69: 3216–3220) highlighted modifications in SGI nomenclature
that led us to rename the ICE in our isolate of P. mirabilis as PGI1.
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